Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDC”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02605954
What this trial is testing

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 275
Large-scale testing (Phase 3)Active Not RecruitingNCT05785767
What this trial is testing

Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals 149
Post-approval studies (Phase 4)Study completedNCT00993187
What this trial is testing

Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 292
Large-scale testing (Phase 3)Active Not RecruitingNCT06868264
What this trial is testing

C-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Who this might be right for
HEPATITIS C VIRUS CHRONIC INFECTION
Atea Pharmaceuticals, Inc. 880
Early research (Phase 1)Ended earlyNCT02608242
What this trial is testing

PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and Rosuvastatin

Who this might be right for
HypertensionHyperlipidemia
Yuhan Corporation 123
Large-scale testing (Phase 3)Study completedNCT01702298
What this trial is testing

Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 42
Early research (Phase 1)Study completedNCT05533073
What this trial is testing

Comparative Bioavailability Study Between Etoricoxib and Tramadol, Administered Individually or in Combination

Who this might be right for
Healthy
Laboratorios Silanes S.A. de C.V. 42
Large-scale testing (Phase 3)Looking for participantsNCT07619131
What this trial is testing

A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.

Who this might be right for
Hypercholesterolaemia
AstraZeneca 600
Testing effectiveness (Phase 2)Study completedNCT01958281
What this trial is testing

Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency

Who this might be right for
HCV Infection
Gilead Sciences 38
Early research (Phase 1)Study completedNCT01002807
What this trial is testing

Bioavailability Study of Fixed Dose Combination (FDC) Formulations of Dapagliflozin and Metformin XR Versus Individual Component Coadministered to Healthy Subjects in a Fasted State

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
AstraZeneca 15
Early research (Phase 1)Study completedNCT00929201
What this trial is testing

Sitagliptin/Metformin Fed Bioequivalence Study (0431A-080)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 61
Large-scale testing (Phase 3)Study completedNCT02600819
What this trial is testing

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of E/C/F/TAF Fixed Dose Combination (FDC) in HIV-1 Infected Adults on Chronic Hemodialysis

Who this might be right for
HIV-1 Infection
Gilead Sciences 55
Testing effectiveness (Phase 2)UnknownNCT02506777
What this trial is testing

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Who this might be right for
Breast Cancer
N.N. Petrov National Medical Research Center of Oncology 96
Post-approval studies (Phase 4)Study completedNCT02603393
What this trial is testing

Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 1,053
Testing effectiveness (Phase 2)Ended earlyNCT04586244
What this trial is testing

An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Incyte Corporation 30
Post-approval studies (Phase 4)UnknownNCT05294952
What this trial is testing

Co Ihibtory Receptor in Preeclampsia

Who this might be right for
Pre-Eclampsia
Assiut University 82
Large-scale testing (Phase 3)Study completedNCT02652624
What this trial is testing

Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women

Who this might be right for
HIV-1 Infection
Gilead Sciences 472
Testing effectiveness (Phase 2)Temporarily pausedNCT06325683
What this trial is testing

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Progressive GlioblastomaRecurrent Glioblastoma
National Cancer Institute (NCI) 184
Testing effectiveness (Phase 2)Study completedNCT03531905
What this trial is testing

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

Who this might be right for
DiabetesDiabetes Mellitus, Type 2Cholesterolemia
Esperion Therapeutics, Inc. 242
Early research (Phase 1)Study completedNCT02121509
What this trial is testing

Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/750mg) Extended Release in Healthy Subjects

Who this might be right for
Healthy
Boehringer Ingelheim 74
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation